Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee

BMC Biotechnology
Carole BloquelMichel Francis Bureau

Abstract

Optical imaging is an attractive non-invasive way to evaluate the expression of a transferred DNA, mainly thanks to its lower cost and ease of realization. In this study optical imaging was evaluated for monitoring and quantification of the mouse knee joint and tibial cranial muscle electrotransfer of a luciferase encoding plasmid. Optical imaging was applied to study the kinetics of luciferase expression in both tissues. The substrate of luciferase (luciferin) was injected either intraperitonealy (i.p.) or in situ into the muscle or the knee joint. Luminescence resulting from the luciferase-luciferin reaction was measured in vivo with a cooled CCD camera and/or in vitro on tissue lysate. Maximal luminescence of the knee joint and muscle after i.p. (2.5 mg) or local injection of luciferin (50 microg in the knee joint, 100 microg in the muscle) were highly correlated. With the local injection procedure adopted, in vivo and in vitro luminescences measured on the same muscles significantly correlated. Luminescence measurements were reproducible and the signal level was proportional to the amount of plasmid injected. In vivo luciferase activity in the electrotransfered knee joint was detected for two weeks. Intramuscular electrotra...Continue Reading

References

Sep 17, 1984·Biochemical and Biophysical Research Communications·M DeLuca, W D McElroy
Oct 25, 1995·Biochimica Et Biophysica Acta·S R FordF R Leach
Feb 21, 1998·Trends in Biotechnology·A Bogdanov, R Weissleder
Jul 17, 1998·British Journal of Urology·K HarimotoT Kishimoto
Sep 22, 1998·Nature Biotechnology·H Aihara, J Miyazaki
Jan 8, 1999·Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie·L M MirD Scherman
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L M MirD Scherman
Aug 17, 1999·Biochemical Pharmacology·L H Naylor
Sep 1, 1999·Gene Therapy·F SoubrierJ Crouzet
Apr 20, 2001·Luminescence : the Journal of Biological and Chemical Luminescence·P BalaguerJ C Nicolas
Jul 5, 2001·The Journal of Gene Medicine·H HerweijerJ A Wolff
Sep 8, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·A HonigmanE Galun
Oct 11, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·J C WuS S Gambhir
Nov 1, 2001·Nature Neuroscience·T Inoue, R Krumlauf
Nov 16, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·J HartikkaM Sawdey
Dec 1, 2001·Journal of Biomedical Optics·B W RiceM B Nelson
Feb 6, 2002·The Journal of Gene Medicine·Kathleen Blair-ParksDavid A Dean
Mar 14, 2002·The American Journal of Pathology·Antoinette WetterwaldMarco G Cecchini
Jun 11, 2002·Biochemical and Biophysical Research Communications·Suzuyo OhashiOsam Mazda
Dec 17, 2002·Nature Medicine·Paolo CianaAdriana Maggi
Apr 15, 2003·Journal of Virology·Susan H Cook, Diane E Griffin
May 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Laurent GrossinPierre Gillet
Jun 26, 2003·The Journal of Gene Medicine·Marc JayankuraDavid Klatzmann
Jan 30, 2004·Biochimica Et Biophysica Acta·M F BureauD Scherman
Feb 21, 2004·Biochemical and Biophysical Research Communications·Luminita H PojogaRichard H Hilderman
Apr 20, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yossi GafniDan Gazit
May 14, 2004·Gene Therapy·K ShahR Weissleder
Jul 9, 2004·The Journal of Gene Medicine·Anne-Cécile DurieuxDamien Freyssenet
Aug 12, 2004·Proceedings of the National Academy of Sciences of the United States of America·Vasilis NtziachristosRalph Weissleder
Feb 16, 2005·The Journal of Gene Medicine·Jin Zhong LiGregory A Helm
Feb 22, 2005·Current Opinion in Biotechnology·David K Welsh, Steve A Kay
Feb 25, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Bakhos A TannousXandra O Breakefield
Apr 21, 2005·Analytical Biochemistry·Arnaud PillonJean-Claude Nicolas

❮ Previous
Next ❯

Citations

Apr 23, 2009·Pharmaceutical Research·Gaëlle VandermeulenVéronique Préat
Oct 19, 2012·Journal of Medicinal Chemistry·Odile Dechy-Cabaret, Françoise Benoit-Vical
Jan 1, 2008·International Journal of Nanomedicine·Miguel N CentellesJuan M Irache
Nov 1, 2015·Gut Microbes·Winschau F van ZylLeon M T Dicks
Oct 20, 2010·FEMS Microbiology Reviews·Nuria AndreuSiouxsie Wiles
Jul 31, 2013·Human Vaccines & Immunotherapeutics·Stefan P PetkovMaria G Isaguliants
Mar 21, 2017·International Journal of Pharmaceutics·Christian LeborgneAntoine Kichler
Jun 9, 2010·The Journal of Gene Medicine·Nathalie MignetDaniel Scherman
Apr 24, 2009·Molecular Pharmaceutics·Christian A Fernandez, Kevin G Rice

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
BRET
transgenic
ELISA

Software Mentioned

β Vision +
Biospace Mesure

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.